🇺🇸 FDA
Patent

US 10172786

Oral care composition comprising cannabinoids

granted A61KA61K2800/28A61K31/352

Quick answer

US patent 10172786 (Oral care composition comprising cannabinoids) held by AXIM BIOTECHNOLOGIES. INC. expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
AXIM BIOTECHNOLOGIES. INC.
Grant date
Tue Jan 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K2800/28, A61K31/352, A61K31/658, A61K8/19